• Return to Headlines

Neogenomics Inc Looks to Continue to Trade Above its Annual-High Share Price Today

By Amy Schwartz

Shares of Neogenomics Inc (NASDAQ:NEO) traded at a new 52-week high today of $10.30. So far today approximately 66,000 shares have been exchanged, as compared to an average 30-day volume of 347,000 shares.

Neogenomics Inc (NASDAQ:NEO) has potential upside of 8.2% based on a current price of $10.22 and analysts' consensus price target of $11.06. The stock should discover initial support at its 50-day moving average (MA) of $6.97 and subsequent support at its 200-day MA of $6.82.

NeoGenomics, Inc. operates a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. The Company's services include cytogenetics, fluorescence in-situhybridization (FISH), flow cytometry, morphology, anatomic pathology, and molecular genetic testing. NeoGenomics serves pathologists, oncologists, urologists, and hospitals.

Neogenomics Inc share prices have moved between a 52-week high of $10.30 and a 52-week low of $6.90 and are now trading 48% above that low price at $10.22 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 2.4%.

SmarTrend recommended that subscribers consider buying shares of Neogenomics Inc on June 12th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $8.23. Since that recommendation, shares of Neogenomics Inc have risen 22.9%. We continue to monitor NEO for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows neogenomics inc

Ticker(s): NEO